Breast Radiotherapy and Early Adverse Cardiac Effects. The Role of Serum Biomarkers and Strain Echocardiography.


Journal

Anticancer research
ISSN: 1791-7530
Titre abrégé: Anticancer Res
Pays: Greece
ID NLM: 8102988

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 04 02 2019
revised: 23 02 2019
accepted: 25 02 2019
entrez: 7 4 2019
pubmed: 7 4 2019
medline: 24 4 2019
Statut: ppublish

Résumé

Breast cancer radiotherapy has a clear benefit for both long-term survival and local recurrence rate. However, there is still much concern about the early radiation-induced heart toxicity. This article aimed to clarify the impact of certain cardiac biomarkers and strain echocardiographic imaging on the detection of early cardiac dysfunction. Several studies that reported changes in either echocardiographic and/or serum levels measurements after breast radiotherapy were searched. Despite the established role of cardiac biomarkers to predict late cardiotoxicity after radiotherapy, data concerning early cardiac damage are still lacking. Furthermore, although strain echocardiography represents a specific tool for the detection of cardiac morbidity in certain diseases, much interest concerns its role in the prediction of early heart failure after radiotherapy. Identification of new tools for the detection of early cardiotoxicity after breast radiotherapy may minimize the side-effects of therapeutic modalities in the clinical setting.

Identifiants

pubmed: 30952705
pii: 39/4/1667
doi: 10.21873/anticanres.13272
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1667-1673

Informations de copyright

Copyright© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Auteurs

Areti Gkantaifi (A)

Radiotherapy Department, Interbalkan Medical Center, Thessaloniki, Greece aretigk1@yahoo.gr.

Christodoulos Papadopoulos (C)

3rd Cardiology Department, Hippokration University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Despoina Spyropoulou (D)

Department of Radiation Oncology, Medical School, University of Patras, Patras, Greece.

Maria Toumpourleka (M)

Second Propedeutic Department of Internal Medicine, Hippokration Hospital, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.

George Iliadis (G)

Radiotherapy Department, Interbalkan Medical Center, Thessaloniki, Greece.

Dimitrios Kardamakis (D)

Department of Radiation Oncology, Medical School, University of Patras, Patras, Greece.

Michail Nikolaou (M)

Oncology Clinic, Hippokration University Hospital of Athens, Athens, Greece.

Nikolaos Tsoukalas (N)

Oncology Department, Veterans Hospital (NIMTS), Athens, Greece.

George Kyrgias (G)

School of Health Sciences, Department of Radiotherapy, Faculty of Medicine, Biopolis, University of Thessaly, Larissa, Greece.

Maria Tolia (M)

School of Health Sciences, Department of Radiotherapy, Faculty of Medicine, Biopolis, University of Thessaly, Larissa, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH